The absence of TRPC4 in renal cell carcinoma results in impaired Ca2+ intake, misfolding, retrograde transport, and diminished antiangiogenic thrombopsonin-1 production, thus enabling angiogenic switch during tumor progression (Veliceasa et al., 2007). Here, TRPC4 is linked to neoplasm.